Cargando…
Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells
KRAS mutations are detected in numerous human cancers, but there are few effective drugs for KRAS‐mutated cancers. Transporters for amino acids and glucose are highly expressed on cancer cells, possibly to maintain rapid cell growth and metabolism. Alanine‐serine‐cysteine transporter 2 (ASCT2) is a...
Autores principales: | Hara, Yuta, Minami, Yushi, Yoshimoto, Soshi, Hayashi, Natsumi, Yamasaki, Akitaka, Ueda, Shiho, Masuko, Kazue, Masuko, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943164/ https://www.ncbi.nlm.nih.gov/pubmed/31709772 http://dx.doi.org/10.1002/cam4.2689 |
Ejemplares similares
-
Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene
por: Okita, Kouki, et al.
Publicado: (2020) -
Anti‐tumor effects of mAb against l‐type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes
por: Ueda, Shiho, et al.
Publicado: (2019) -
Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target
por: Hayashi, Natsumi, et al.
Publicado: (2021) -
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers
por: Okita, Kouki, et al.
Publicado: (2020) -
Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1
por: Hara, Yuta, et al.
Publicado: (2018)